APLM Apollomics Inc. - Class A Ordinary Shares
APLM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
APLM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
APLM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 2 28.6%
- Buy 4 57.1%
- Hold 1 14.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 4 filers · $224K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 1 (0 vs prior Q) | 1 (0 vs prior Q) | 0 (0 vs prior Q) | 0 (0 vs prior Q) | +10K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | $223,517 | 10,664 | 99.89% | Shares |
| SBI Securities Co., Ltd. | $189 | 9 | 0.08% | Shares |
| UBS Group AG | $42 | 2 | 0.02% | Shares |
| BlackRock, Inc. | $21 | 1 | 0.01% | Shares |
Company insiders 2 insiders · 1 officers · 1 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Peter Kuan-How Lin | Chief Financial Officer | March 31, 2026 F | 12,318 | 0 | 0 | $0 |
| Ya-Chi Huang | Director | May 17, 2026 M | 1,000 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Yi-Kuei Chen | April 8, 2026 | 5.30% | Initial filing | — | SEC |
| Hung-Wen Chen, King Regent Management Limited ×2 filings | April 6, 2026 | 41.80% | Amendment | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Asia GP II, L.P., OrbiMed Advisors II Limited ×7 filings | Aug. 15, 2024 | — | Initial filing | — | SEC |
| Guo-Liang Yu | Oct. 10, 2023 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.